Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate H Gartlan

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
Nature Biotechnology|August 28, 2012
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensFrank Wegmann, Kate H Gartlan, Ali M Harandi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2017
A critical role for donor-derived IL-22 in cutaneous chronic GVHDKate H Gartlan, Hemamalini Bommiasamy, Katelyn Paz, et al.
The Journal of Clinical Investigation|April 10, 2018
Recipient mucosal-associated invariant T cells control GVHD within the colonAntiopi Varelias, Mark D Bunting, Kate L Ormerod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T CellsPing Zhang, Jyothy Raju, Md Ashik Ullah, et al.
Blood Advances|January 4, 2018
Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCTKate H Gartlan, Antiopi Varelias, Motoko Koyama, et al.
Blood|August 26, 2021
IFN-λ therapy prevents severe gastrointestinal graft-versus-host diseaseAndrea S Henden, Motoko Koyama, Renee J Robb, et al.
Immunity|October 3, 2025
Eomesodermin<sup>+</sup> CD4<sup>+</sup> T cells are critical for curative immunotherapy outcomesPing Zhang, Françoise Haeseleer, Olivia G Waltner, et al.
The Lancet. Oncology|December 3, 2014
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trialGlen A Kennedy, Antiopi Varelias, Slavica Vuckovic, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
Nature Biotechnology|August 28, 2012
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensFrank Wegmann, Kate H Gartlan, Ali M Harandi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2017
A critical role for donor-derived IL-22 in cutaneous chronic GVHDKate H Gartlan, Hemamalini Bommiasamy, Katelyn Paz, et al.
The Journal of Clinical Investigation|April 10, 2018
Recipient mucosal-associated invariant T cells control GVHD within the colonAntiopi Varelias, Mark D Bunting, Kate L Ormerod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T CellsPing Zhang, Jyothy Raju, Md Ashik Ullah, et al.
Blood Advances|January 4, 2018
Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCTKate H Gartlan, Antiopi Varelias, Motoko Koyama, et al.
Blood|August 26, 2021
IFN-λ therapy prevents severe gastrointestinal graft-versus-host diseaseAndrea S Henden, Motoko Koyama, Renee J Robb, et al.
Immunity|October 3, 2025
Eomesodermin<sup>+</sup> CD4<sup>+</sup> T cells are critical for curative immunotherapy outcomesPing Zhang, Françoise Haeseleer, Olivia G Waltner, et al.
The Lancet. Oncology|December 3, 2014
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trialGlen A Kennedy, Antiopi Varelias, Slavica Vuckovic, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Pageof 5